The pathophysiological role of astrocytic endothelin-1

Progress in Neurobiology

Volumn 144, Issue , 2016, Pages 88-102

  Hostenbach, Stéphanie ^a   D'haeseleer, Miguel ^a,b   Kooijman, Ron ^c   De Keyser, Jacques ^a,d  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b National Multiple Sclerosis Center   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Astrocytes; Astrocytoma; Astrogliosis; Blood Brain barrier; Cerebral blood flow; Endothelin 1; Neurological disorders; Pain

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; ASTROCYTOMA; BACTERIAL MENINGITIS; BINSWANGER ENCEPHALOPATHY; BLOOD BRAIN BARRIER; BLOOD VESSEL FUNCTION; BRAIN DAMAGE; BRAIN ISCHEMIA; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM INFECTION; CEREBRAL MALARIA; DEMENTIA; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW (TOPIC); TRAUMATIC BRAIN INJURY; VIRUS INFECTION; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASE; METABOLISM; NEUROPROTECTION; PHYSIOLOGY;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM DISEASES; ENDOTHELIN-1; HUMANS; NEUROPROTECTION;

EID: 84964878089     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2016.04.009     Document Type: Review

References (205)

1. Aboul-Enein, F., Lassmann, H., Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease?. Acta Neuropathol. 109 (2005), 49–55.
2. Aboul-Enein, F., Rauschka, H., Kornek, B., Stadelmann, C., Stefferl, A., Bruck, W., Lucchinetti, C., Schmidbauer, M., Jellinger, K., Lassmann, H., Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J. Neuropathol. Exp. Neurol. 62 (2003), 25–33.
3. Ahmedat, A.S., Warnken, M., Juergens, U.R., Paul Pieper, M., Racke, K., beta(2)-adrenoceptors and muscarinic receptors mediate opposing effects on endothelin-1 expression in human lung fibroblasts. Eur. J. Pharmacol. 691 (2012), 218–224.
4. Akiyama, H., Ikeda, K., Kondo, H., McGeer, P.L., Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci. Lett. 146 (1992), 152–154.
5. Aliev, G., Smith, M.A., Obrenovich, M.E., de la Torre, J.C., Perry, G., Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotox. Res. 5 (2003), 491–504.
6. Aliev, G., Oxidative stress induced-metabolic imbalance, mitochondrial failure, and cellular hypoperfusion as primary pathogenetic factors for the development of Alzheimer disease which can be used as a alternate and successful drug treatment strategy: past, present and future. CNS Neurol. Disord. Drug Targets 10 (2011), 147–148.
7. Alioglu, Z., Orem, A., Bulbul, I., Boz, C., Ozmenoglu, M., Vanizor, B., Evaluation of plasma endothelin-1 levels in patients with cerebral infarction. Angiology 53 (2002), 77–82.
8. Allritz, C., Bette, S., Figiel, M., Engele, J., Comparative structural and functional analysis of the GLT-1/EAAT-2 promoter from man and rat. J. Neurosci. Res. 88 (2010), 1234–1241.
9. Appin, C.L., Brat, D.J., Molecular pathways in gliomagenesis and their relevance to neuropathologic diagnosis. Adv. Anat. Pathol. 22 (2015), 50–58.
10. Barker, R., Wellington, D., Esiri, M.M., Love, S., Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins. J. Cereb. Blood Flow Metab. 33 (2013), 1050–1057.
11. Barker, R., Ashby, E.L., Wellington, D., Barrow, V.M., Palmer, J.C., Kehoe, P.G., Esiri, M.M., Love, S., Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. Brain 137 (2014), 1524–1532.
12. Barnett, M.H., Prineas, J.W., Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55 (2004), 458–468.
13. Barone, F.C., Globus, M.Y., Price, W.J., White, R.F., Storer, B.L., Feuerstein, G.Z., Busto, R., Ohlstein, E.H., Endothelin levels increase in rat focal and global ischemia. J. Cereb. Blood Flow Metab. 14 (1994), 337–342.
14. Basilico, N., Speciale, L., Parapini, S., Ferrante, P., Taramelli, D., Endothelin-1 production by an microvascular endothelial cell line treated with Plasmodium falciparum parasitized red blood cells. Clin. Sci. 103 (2002), 464S–466S.
15. Blomstrand, F., Giaume, C., Hansson, E., Ronnback, L., Distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca(2+) signaling. Am. J. Physiol. 277 (1999), C616–627.
16. Bremnes, T., Paasche, J.D., Mehlum, A., Sandberg, C., Bremnes, B., Attramadal, H., Regulation and intracellular trafficking pathways of the endothelin receptors. J. Biol. Chem. 275 (2000), 17596–17604.
17. Briyal, S., Shepard, C., Gulati, A., Endothelin receptor type B agonist, IRL-1620, prevents beta amyloid (Abeta) induced oxidative stress and cognitive impairment in normal and diabetic rats. Pharmacol. Biochem. Behav. 120 (2014), 65–72.
18. Brumm, K.P., Perthen, J.E., Liu, T.T., Haist, F., Ayalon, L., Love, T., An arterial spin labeling investigation of cerebral blood flow deficits in chronic stroke survivors. Neuroimage 51 (2010), 995–1005.
19. Brun, A., Englund, E., A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 19 (1986), 253–262.
20. Burda, J.E., Sofroniew, M.V., Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81 (2014), 229–248.
21. Callera, G.E., Montezano, A.C., Touyz, R.M., Zorn, T.M., Carvalho, M.H., Fortes, Z.B., Nigro, D., Schiffrin, E.L., Tostes, R.C., ETA receptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA-salt rats. Hypertension 43 (2004), 872–879.
22. Cernak, I., Vink, R., Natale, J., Stoica, B., Lea, P.M.T., Movsesyan, V., Ahmed, F., Knoblach, S.M., Fricke, S.T., Faden, A.I., The dark side of endocannabinoids: a neurotoxic role for anandamide. J. Cereb. Blood Flow Metab. 24 (2004), 564–578.
23. Chang, A., Tourtellotte, W.W., Rudick, R., Trapp, B.D., Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346 (2002), 165–173.
24. Chatfield, D.A., Brahmbhatt, D.H., Sharp, T., Perkes, I.E., Outrim, J.G., Menon, D.K., Juguloarterial endothelin-1 gradients after severe traumatic brain injury. Neurocrit. Care 14 (2011), 55–60.
25. Chauhan, A., Hahn, S., Gartner, S., Pardo, C.A., Netesan, S.K., McArthur, J., Nath, A., Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins. FASEB J. 21 (2007), 777–789.
26. Chen, C.F., Guo, S.S., Jia, H.Y., Dai, J.X., Xue, S.W., The role of endothelin-1 in Binswanger's disease. Zhonghua Yi Xue Za Zhi (Taipei) 58 (1996), 151–155.
27. Chen, H., Kintner, D.B., Jones, M., Matsuda, T., Baba, A., Kiedrowski, L., Sun, D., AMPA-mediated excitotoxicity in oligodendrocytes: role for Na(+)-K(+)-Cl(−) co-transport and reversal of Na(+)/Ca(2+) exchanger. J. Neurochem. 102 (2007), 1783–1795.
28. Chen, G., Tariq, A., Ai, J., Sabri, M., Jeon, H.J., Tang, E.J., Lakovic, K., Wan, H., Macdonald, R.L., Different effects of clazosentan on consequences of subarachnoid hemorrhage in rats. Brain Res. 1392 (2011), 132–139.
29. Chen, M.J., Kress, B., Han, X., Moll, K., Peng, W., Ji, R.R., Nedergaard, M., Astrocytic CX43 hemichannels and gap junctions play a crucial role in development of chronic neuropathic pain following spinal cord injury. Glia 60 (2012), 1660–1670.
30. Chen, A.D., Xiong, X.Q., Gan, X.B., Zhang, F., Zhou, Y.B., Gao, X.Y., Han, Y., Endothelin-1 in paraventricular nucleus modulates cardiac sympathetic afferent reflex and sympathetic activity in rats. PLoS One, 7, 2012, e40748.
31. Chen, B., Friedman, B., Whitney, M.A., Winkle, J.A., Lei, I.F., Olson, E.S., Cheng, Q., Pereira, B., Zhao, L., Tsien, R.Y., Lyden, P.D., Thrombin activity associated with neuronal damage during acute focal ischemia. J. Neurosci. 32 (2012), 7622–7631.
32. Chen, G., Park, C.K., Xie, R.G., Berta, T., Nedergaard, M., Ji, R.R., Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice. Brain 137 (2014), 2193–2209.
33. Chuquet, J., Benchenane, K., Toutain, J., MacKenzie, E.T., Roussel, S., Touzani, O., Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat. Stroke 33 (2002), 3019–3025.
34. Clerk, A., Sugden, P.H., Regulation of phospholipases C and D in rat ventricular myocytes: stimulation by endothelin-1, bradykinin and phenylephrine. J. Mol. Cell Cardiol. 29 (1997), 1593–1604.
35. Cohen, A.L., Colman, H., Glioma biology and molecular markers. Cancer Treat. Res. 163 (2015), 15–30.
36. Compston, A., Coles, A., Multiple sclerosis. Lancet 372 (2008), 1502–1517.
37. Confavreux, C., Vukusic, S., Age at disability milestones in multiple sclerosis. Brain 129 (2006), 595–605.
38. Confavreux, C., Vukusic, S., Moreau, T., Adeleine, P., Relapses and progression of disability in multiple sclerosis. N. Engl. J. Med. 343 (2000), 1430–1438.
39. D'Haeseleer, M., Beelen, R., Fierens, Y., Cambron, M., Vanbinst, A.M., Verborgh, C., Demey, J., De Keyser, J., Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 5654–5658.
40. D'Haeseleer, M., Hostenbach, S., Peeters, I., Sankari, S.E., Nagels, G., De Keyser, J., D'Hooghe, M., Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?. J. Cereb. Blood Flow Metab. 35:9 (2015), 1406–1410.
41. Dai, M., Freeman, B., Bruno, F.P., Shikani, H.J., Tanowitz, H.B., Weiss, L.M., Reznik, S.E., Stephani, R.A., Desruisseaux, M.S., The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with artemisinin derivative. Life Sci. 91 (2012), 687–692.
42. Davenport, A.P., International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol. Rev. 54 (2002), 219–226.
43. De Keyser, J., Wilczak, N., Leta, R., Streetland, C., Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology 53 (1999), 1628–1633.
44. Desai, D., He, S., Yorio, T., Krishnamoorthy, R.R., Prasanna, G., Hypoxia augments TNF-alpha-mediated endothelin-1 release and cell proliferation in human optic nerve head astrocytes. Biochem. Biophys. Res. Commun. 318 (2004), 642–648.
45. Didier, N., Banks, W.A., Creminon, C., Dereuddre-Bosquet, N., Mabondzo, A., HIV-1-induced production of endothelin-1 in an in vitro model of the human blood-brain barrier. Neuroreport 13 (2002), 1179–1183.
46. Dietmann, A., Lackner, P., Helbok, R., Spora, K., Issifou, S., Lell, B., Reindl, M., Kremsner, P.G., Schmutzhard, E., Opposed circulation plasma levels of endothelin-1 and C-type natriuretic peptide in childre with Plasmodium falciparum malaria. Malar. J., 15, 2008, 253.
47. Dore-Duffy, P., Wang, S., Mehedi, A., Katyshev, V., Cleary, K., Tapper, A., Reynolds, C., Ding, Y., Zhan, P., Rafols, J., Kreipke, C.W., Pericyte-mediated vasoconstriction underlies TBI-induced hypoperfusion. Neurol. Res. 33 (2011), 176–186.
48. Egidy, G., Eberl, L.P., Valdenaire, O., Irmler, M., Majdi, R., Diserens, A.C., Fontana, A., Janzer, R.C., Pinet, F., Juillerat-Jeanneret, L., The endothelin system in human glioblastoma. Lab. Invest. 80 (2000), 1681–1689.
49. Ehrenreich, H., Kehrl, J.H., Anderson, R.W., Rieckmann, P., Vitkovic, L., Coligan, J.E., Fauci, A.S., A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes. Brain Res. 538 (1991), 54–58.
50. Ehrenreich, H., Costa, T., Clouse, K.A., Pluta, R.M., Ogino, Y., Coligan, J.E., Burd, P.R., Thrombin is a regulator of astrocytic endothelin-1. Brain Res. 600 (1993), 201–207.
51. Farkas, E., Donka, G., de Vos, R.A., Mihaly, A., Bari, F., Luiten, P.G., Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathol. 108 (2004), 57–64.
52. Farkas, E., Luiten, P.G., Bari, F., Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res. Rev. 54 (2007), 162–180.
53. Fernando, M.S., Simpson, J.E., Matthews, F., Brayne, C., Lewis, C.E., Barber, R., Kalaria, R.N., Forster, G., Esteves, F., Wharton, S.B., Shaw, P.J., O'Brien, J.T., Ince, P.G., White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 37 (2006), 1391–1398.
54. Firbank, M.J., He, J., Blamire, A.M., Singh, B., Danson, P., Kalaria, R.N., O'Brien, J.T., Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology 76 (2011), 1478–1484.
55. Freedman, N.J., Ament, A.S., Oppermann, M., Stoffel, R.H., Exum, S.T., Lefkowitz, R.J., Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G protein-coupled receptor kinase specificity. J. Biol. Chem. 272 (1997), 17734–17743.
56. Freeman, B.D., Machado, F.S., Tanowitz, H.B., Desruisseaux, M.S., Endothelin-1 and its role in the pathogenesis of infectious diseases. Life Sci. 118 (2014), 110–119.
57. Friedlaender, M.M., Jain, D., Ahmed, Z., Hart, D., Barnett, R.L., Nord, E.P., Endothelin activation of phospholipase D: dual modulation by protein kinase C and Ca2+. Am. J. Physiol. 264 (1993), F845–853.
58. Fukuroda, T., Fujikawa, T., Ozaki, S., Ishikawa, K., Yano, M., Nishikibe, M., Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem. Biophys. Res. Commun. 199 (1994), 1461–1465.
59. Gadea, A., Schinelli, S., Gallo, V., Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway. J. Neurosci. 28 (2008), 2394–2408.
60. Gajkowska, B., Endothelin-like immunoreactivity in hippocampus following transient global cerebral ischemia. I. Neuronal and glial cells. Folia Neuropathol. 35 (1997), 36–48.
61. Gemmell, E., Bosomworth, H., Allan, L., Hall, R., Khundakar, A., Oakley, A.E., Deramecourt, V., Polvikoski, T.M., O'Brien, J.T., Kalaria, R.N., Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias. Stroke 43 (2012), 808–814.
62. Giaid, A., Gibson, S.J., Herrero, M.T., Gentleman, S., Legon, S., Yanagisawa, M., Masaki, T., Ibrahim, N.B., Roberts, G.W., Rossi, M.L., et al. Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry 95 (1991), 303–314.
63. Giaume, C., Cordier, J., Glowinski, J., Endothelins inhibit junctional permeability in cultured mouse astrocytes. Eur. J. Neurosci. 4 (1992), 877–881.
64. Graumann, U., Reynolds, R., Steck, A.J., Schaeren-Wiemers, N., Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 13 (2003), 554–573.
65. Gregan, B., Jurgensen, J., Papsdorf, G., Furkert, J., Schaefer, M., Beyermann, M., Rosenthal, W., Oksche, A., Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J. Biol. Chem. 279 (2004), 27679–27687.
66. Guo, Y., Chung, S.K., Siu, C.W., Kwan, S.C., Ho, P.W., Yeung, P.K., Chan, K.H., Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis. J. Neuroimmunol. 276 (2014), 64–70.
67. Gupta, Y.K., Briyal, S., Sharma, U., Jaganathan, N.R., Gulati, A., Effect of endothelin antagonist (TAK-044) on cerebral ischemic volume, oxidative stress markers and neurobehavioral parameters in the middle cerebral artery occlusion model of stroke in rats. Life Sci. 77 (2005), 15–27.
68. Hammond, T.R., Gadea, A., Dupree, J., Kerninon, C., Nait-Oumesmar, B., Aguirre, A., Gallo, V., Astrocyte-derived endothelin-1 inhibits remyelination through notch activation. Neuron 81 (2014), 588–602.
69. Hammond, T.R., McEllin, B., Morton, P.D., Raymond, M., Dupree, J., Gallo, V., Endothelin-B Receptor Activation in Astrocytes Regulates the Rate of Oligodendrocyte Regeneration during Remyelination. Cell Rep. 13:10 (2015), 2090–2097.
70. Han, M.H., Hwang, S.I., Roy, D.B., Lundgren, D.H., Price, J.V., Ousman, S.S., Fernald, G.H., Gerlitz, B., Robinson, W.H., Baranzini, S.E., Grinnell, B.W., Raine, C.S., Sobel, R.A., Han, D.K., Steinman, L., Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451 (2008), 1076–1081.
71. Hanaoka, T., Kimura, N., Aso, Y., Takemaru, M., Kimura, Y., Ishibashi, M., Matsubara, E., Relationship between white matter lesions and regional cerebral blood flow changes during longitudinal follow up in Alzheimer's disease. Geriatr. Gerontol. Int., 2015, 10.1111/ggi.12563.
72. Hasselblatt, M., Lewczuk, P., Loffler, B.M., Kamrowski-Kruck, H., von Ahsen, N., Siren, A.L., Ehrenreich, H., Role of the astrocytic ET(B) receptor in the regulation of extracellular endothelin-1 during hypoxia. Glia 34 (2001), 18–26.
73. Ho, M.C., Lo, A.C., Kurihara, H., Yu, A.C., Chung, S.S., Chung, S.K., Endothelin-1 protects astrocytes from hypoxic/ischemic injury. FASEB J. 15 (2001), 618–626.
74. Holland, C.M., Charil, A., Csapo, I., Liptak, Z., Ichise, M., Khoury, S.J., Bakshi, R., Weiner, H.L., Guttmann, C.R., The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis. J. Neuroimaging 22 (2012), 129–136.
75. Hong, L.Z., Zhao, X.Y., Zhang, H.L., p53-mediated neuronal cell death in ischemic brain injury. Neurosci. Bull. 26 (2010), 232–240.
76. Hsieh, W.T., Yeh, W.L., Cheng, R.Y., Lin, C., Tsai, C.F., Huang, B.R., Wu, C.Y., Lin, H.Y., Huang, S.S., Lu, D.Y., Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme. J. Neurooncol. 118 (2014), 257–269.
77. Hung, V.K., Chen, S.M., Tai, L.W., Chen, A.Y., Chung, S.K., Cheung, C.W., Over-expression of endothelin-1 in astrocytes, but not endothelial cells, ameliorates inflammatory pain response after formalin injection. Life Sci. 91 (2012), 618–622.
78. Hung, V.K., Tai, L.W., Qiu, Q., Luo, X., Wong, K.L., Chung, S.K., Cheung, C.W., Over-expression of astrocytic ET-1 attenuates neuropathic pain by inhibition of ERK1/2 and Akt(s) via activation of ETA receptor. Mol. Cell. Neurosci. 60 (2014), 26–35.
79. Hung, V.K., Yeung, P.K., Lai, A.K., Ho, M.C., Lo, A.C., Chan, K.C., Wu, E.X., Chung, S.S., Cheung, C.W., Chung, S.K., Selective astrocytic endothelin-1 overexpression contributes to dementia associated with ischemic stroke by exaggerating astrocyte-derived amyloid secretion. J Cereb Blood Flow Metab 5:10 (2015), 1687–1696.
80. Ilieva, H., Polymenidou, M., Cleveland, D.W., Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187 (2009), 761–772.
81. Ishikawa, M., Cooper, D., Arumugam, T.V., Zhang, J.H., Nanda, A., Granger, D.N., Platelet-leukocyte-endothelial cell interactions after middle cerebral artery occlusion and reperfusion. J. Cereb. Blood Flow Metab. 24 (2004), 907–915.
82. Jiang, M.H., Eriksson, L., Olsson, Y., Immunohistochemical evidence of endothelin-1 in human choroid plexus. Acta Neuropathol. 84 (1992), 457–460.
83. Jiang, M.H., Hoog, A., Ma, K.C., Nie, X.J., Olsson, Y., Zhang, W.W., Endothelin-1-like immunoreactivity is expressed in human reactive astrocytes. Neuroreport 4 (1993), 935–937.
84. Kallakuri, S., Kreipke, C.W., Schafer, P.C., Schafer, S.M., Rafols, J.A., Brain cellular localization of endothelin receptors A and B in a rodent model of diffuse traumatic brain injury. Neuroscience 168 (2010), 820–830.
85. Kaplan, B.L., The role of CB1 in immune modulation by cannabinoids. Pharmacol. Ther. 137 (2013), 365–374.
86. Karne, S., Jayawickreme, C.K., Lerner, M.R., Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J. Biol. Chem. 268 (1993), 19126–19133.
87. Kedzierski, R.M., Yanagisawa, M., Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 41 (2001), 851–876.
88. Khimji, A.K., Rockey, D.C., Endothelin–biology and disease. Cell. Signal. 22 (2010), 1615–1625.
89. Khodorova, A., Montmayeur, J.P., Strichartz, G., Endothelin receptors and pain. J. Pain 10 (2009), 4–28.
90. Kimura, N., Nakama, H., Nakamura, K., Aso, Y., Kumamoto, T., Effect of white matter lesions on brain perfusion in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 34 (2012), 256–261.
91. Koch, M., Mostert, J., Heersema, D., De Keyser, J., Progression in multiple sclerosis: further evidence of an age dependent process. J. Neurol. Sci. 255 (2007), 35–41.
92. Koedel, U., Gorriz, C., Lorenzi, S., Pfister, H.W., Increased endothelin levels in cerebrospinal fluid sampjes form adults with bacterial meningitis. Clin. Infect. Dis. 25 (1997), 329–330.
93. Koedel, U., Lorenzi, S., Gorriz, C., Arendt, R.M., Pfister, H.W., Endothelin B receptor-mediated increase of cerebral blood flow in experimental pneumococcal meningitis. J. Cereb. Blood Flow Metab. 18 (1998), 67–74.
94. Kolias, A.G., Sen, J., Belli, A., Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. J. Neurosci. Res. 87 (2009), 1–11.
95. Koseki, C., Imai, M., Hirata, Y., Yanagisawa, M., Masaki, T., Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide?. Am. J. Physiol. 256 (1989), R858–866.
96. Koyama, Y., Michinaga, S., Regulations of astrocytic functions by endothelins: roles in the pathophysiological responses of damaged brains. J. Pharmacol. Sci. 118 (2012), 401–407.
97. Koyama, Y., Tanaka, K., Decreases in rat brain aquaporin-4 expression following intracerebroventricular administration of an endothelin ET B receptor agonist. Neurosci. Lett. 469 (2010), 343–347.
98. Koyama, Y., Tsujikawa, K., Matsuda, T., Baba, A., Intracerebroventricular administration of an endothelin ETB receptor agonist increases expressions of GDNF and BDNF in rat brain. Eur. J. Neurosci. 18 (2003), 887–894.
99. Koyama, Y., Yoshioka, Y., Shinde, M., Matsuda, T., Baba, A., Focal adhesion kinase mediates endothelin-induced cyclin D3 expression in rat cultured astrocytes. J. Neurochem. 90 (2004), 904–912.
100. Koyama, Y., Baba, A., Matsuda, T., Endothelins stimulate the expression of neurotrophin-3 in rat brain and rat cultured astrocytes. Neuroscience 136 (2005), 425–433.
101. Koyama, Y., Kotani, M., Sawamura, T., Kuribayashi, M., Konishi, R., Michinaga, S., Different actions of endothelin-1 on chemokine production in rat cultured astrocytes: reduction of CX3CL1/fractalkine and an increase in CCL2/MCP-1 and CXCL1/CINC-1. J. Neuroinflammation, 10, 2013, 51.
102. Kreipke, C.W., Rafols, J.A., Reynolds, C.A., Schafer, S., Marinica, A., Bedford, C., Fronczak, M., Kuhn, D., Armstead, W.M., Clazosentan, a novel endothelin A antagonist, improves cerebral blood flow and behavior after traumatic brain injury. Neurol. Res. 33 (2011), 208–213.
103. Kurihara, Y., Kurihara, H., Suzuki, H., Kodama, T., Maemura, K., Nagai, R., Oda, H., Kuwaki, T., Cao, W.H., Kamada, N., et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368 (1994), 703–710.
104. Kuwaki, T., Ling, G.Y., Onodera, M., Ishii, T., Nakamura, A., Ju, K.H., Cao, W.H., Kumada, M., Kurihara, H., Kurihara, Y., Yazaki, Y., Ohuchi, T., Yanagisawa, M., Fukuda, Y., Endothelin in the central control of cardiovascular and respiratory functions. Clin. Exp. Pharmacol. Physiol. 26 (1999), 989–994.
105. Kwan, A.L., Lin, C.L., Chang, C.Z., Winardi, D., Yen, C.P., Wu, S.C., Lee, K.S., Kassell, N.F., Howng, S.L., Savage, P., Jeng, A.Y., Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits. Clin. Sci. (Lond.) 103:Suppl. (48) (2002), 414S–417S.
106. Laban, K.G., Vergouwen, M.D., Dijkhuizen, R.M., Sena, E.S., Macleod, M.R., Rinkel, G.J., van der Worp, H.B., Effect of endothelin receptor antagonists on clinically relevant outcomes after experimental subarachnoid hemorrhage: a systematic review and meta-analysis. J. Cereb. Blood Flow Metab. 35 (2015), 1085–1089.
107. Ladenheim, R.G., Lacroix, I., Foignant-Chaverot, N., Strosberg, A.D., Couraud, P.O., Endothelins stimulate c-fos and nerve growth factor expression in astrocytes and astrocytoma. J. Neurochem. 60 (1993), 260–266.
108. Landucci, E., Scartabelli, T., Gerace, E., Moroni, F., Pellegrini-Giampietro, D.E., CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices. Neuropharmacology 60 (2011), 674–682.
109. Lassmann, H., Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J. Neurol. Sci. 206 (2003), 187–191.
110. LeComte, M.D., Shimada, I.S., Sherwin, C., Spees, J.L., Notch1-STAT3-ETBR signaling axis controls reactive astrocyte proliferation after brain injury. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 8726–8731.
111. Lee, M., de la Monte, S., Ng, S., Bloch, K., Quertermous, T., Expression of the potent vasoconstrictor endothelin in the human central nervous system. J. Clin. Invest. 86 (1990), 141–147.
112. Lee, M.E., de la Monte, S.M., Ng, S.C., Bloch, K.D., Quertermous, T., Expression of the potent vasoconstrictor endothelin in the human central nervous system. J. Clin. Invest. 86 (1990), 141–147.
113. Lee, S.H., Coutu, J.P., Wilkens, P., Yendiki, A., Rosas, H.D., Salat, D.H., Alzheimer's disease Neuroimaging Initiative, Tract-based analysis of white matter degeneration in Alzheimer's disease. Neuroscience 301 (2015), 79–89.
114. Lehmberg, J., Putz, C., Furst, M., Beck, J., Baethmann, A., Uhl, E., Impact of the endothelin-A receptor antagonist BQ 610 on microcirculation in global cerebral ischemia and reperfusion. Brain Res. 961 (2003), 277–286.
115. Lei, Q., Li, S., Zheng, R., Xu, K., Li, S., Endothelin-1 expression and alterations of cerebral microcirculation after experimental subarachnoid hemorrhage. Neuroradiology, 57(1), 2014.
116. Leonard, M.G., Briyal, S., Gulati, A., Endothelin B receptor agonist, IRL-1620, provides long-term neuroprotection in cerebral ischemia in rats. Brain Res. 1464 (2012), 14–23.
117. Leonard, M.G., Prazad, P., Puppala, B., Gulati, A., Selective endothelin-B receptor stimulation increases vascular endothelial growth factor in the rat brain during postnatal development. Drug Res. (Stuttg.) 65 (2015), 607–613.
118. Leung, J.W., Chung, S.S., Chung, S.K., Endothelial endothelin-1 over-expression using receptor tyrosine kinase tie-1 promoter leads to more severe vascular permeability and blood brain barrier breakdown after transient middle cerebral artery occlusion. Brain Res. 1266 (2009), 121–129.
119. Lo, A.C., Chen, A.Y., Hung, V.K., Yaw, L.P., Fung, M.K., Ho, M.C., Tsang, M.C., Chung, S.S., Chung, S.K., Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. J. Cereb. Blood Flow Metab. 25 (2005), 998–1011.
120. Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., Lassmann, H., Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000), 707–717.
121. Ma, K.C., Nie, X.J., Hoog, A., Olsson, Y., Zhang, W.W., Reactive astrocytes in viral infections of the human brain express endothelin-like immunoreactivity. J. Neurol. Sci. 126 (1994), 184–192.
122. Ma, J., Huang, S., Ma, L., Liu, Y., Li, H., You, C., Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials. Crit. Care, 16, 2012, R198.
123. Macdonald, R.L., Kassell, N.F., Mayer, S., Ruefenacht, D., Schmiedek, P., Weidauer, S., Frey, A., Roux, S., Pasqualin, A., Investigators, C.-, Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39 (2008), 3015–3021.
124. Macdonald, R.L., Higashida, R.T., Keller, E., Mayer, S.A., Molyneux, A., Raabe, A., Vajkoczy, P., Wanke, I., Bach, D., Frey, A., Nowbakht, P., Roux, S., Kassell, N., Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 43 (2012), 1463–1469.
125. Machado, F.S., Desruisseaux, M.S., Nagajypthi Kennan, R.P., Hetherington, H.P., Wittner, M., Weiss, L.M., Lee, S.C., Scherer, P.E., Tsuji, M., Tanowitz, H.B., Endothelin in a murine model of cerebral malaria. Exp. Biol. Med. (Maywood) 231 (2006), 1176–1181.
126. Macrae, I.M., Robinson, M.J., Graham, D.I., Reid, J.L., McCulloch, J., Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. J. Cereb. Blood Flow Metab. 13 (1993), 276–284.
127. Maguire, J.J., Davenport, A.P., Endothelin@25—new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12. Br. J. Pharmacol. 171 (2014), 5555–5572.
128. Mallucci, G., Peruzzotti-Jametti, L., Bernstock, J.D., Pluchino, S., The role of immune cells: glia and neurons in white and gray matter pathology in multiple sclerosis. Prog. Neurobiol. 127–128 (2015), 1–22.
129. Matsuo, Y., Kihara, T., Ikeda, M., Ninomiya, M., Onodera, H., Kogure, K., Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: effect of neutrophil depletion on extracellular ascorbyl radical formation. J. Cereb. Blood Flow Metab. 15 (1995), 941–947.
130. Metna-Laurent, M., Marsicano, G., Rising stars: modulation of brain functions by astroglial type-1 cannabinoid receptors. Glia 63 (2015), 353–364.
131. Michinaga, S., Seno, N., Fuka, M., Yamamoto, Y., Minami, S., Kimura, A., Hatanaka, S., Nagase, M., Matsuyama, E., Yamanaka, D., Koyama, Y., Improvement of cold injury-induced mouse brain edema by endothelin ETB antagonists is accompanied by decreases in matrixmetalloproteinase 9 and vascular endothelial growth factor-A. Eur. J. Neurosci. 42 (2015), 2356–2370.
132. Moldes, O., Sobrino, T., Millan, M., Castellanos, M., Perez de la Ossa, N., Leira, R., Serena, J., Vivancos, J., Davalos, A., Castillo, J., High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA. Stroke 39 (2008), 2006–2010.
133. Moldes, O., Sobrino, T., Blanco, M., Agulla, J., Barral, D., Ramos-Cabrer, P., Castillo, J., Neuroprotection afforded by antagonists of endothelin-1 receptors in experimental stroke. Neuropharmacology 63 (2012), 1279–1285.
134. Morga, E., Faber, C., Heuschling, P., Stimulation of endothelin B receptor modulates the inflammatory activation of rat astrocytes. J. Neurochem. 74 (2000), 603–612.
135. Murakami, K., Kondo, T., Yang, G., Chen, S.F., Morita-Fujimura, Y., Chan, P.H., Cold injury in mice: a model to study mechanisms of brain edema and neuronal apoptosis. Prog. Neurobiol. 57 (1999), 289–299.
136. Naidoo, V., Naidoo, S., Mahabeer, R., Raidoo, D.M., Cellular distribution of the endothelin system in the human brain. J. Chem. Neuroanat. 27 (2004), 87–98.
137. Naidoo, V., Naidoo, S., Raidoo, D.M., Immunolocalisation of endothelin-1 in human brain. J. Chem. Neuroanat. 27 (2004), 193–200.
138. Naidoo, V., Naidoo, S., Mahabeer, R., Raidoo, D.M., Localization of the endothelin system in human diffuse astrocytomas. Cancer 104 (2005), 1049–1057.
139. Nakajima, M., Morimoto, S., Takamoto, S., Kitano, S., Fukuo, K., Onishi, T., Ogihara, T., Endothelin-1 in cerebrospinal fluid in elderly patients with hypertension and dementia. Hypertension 24 (1994), 97–100.
140. Narayana, P.A., Zhou, Y., Hasan, K.M., Datta, S., Sun, X., Wolinsky, J.S., Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis. Mult. Scler. 20 (2014), 365–373.
141. Narushima, I., Kita, T., Kubo, K., Yonetani, Y., Momochi, C., Yoshikawa, I., Ohno, N., Nakashima, T., Highly enhanced permeability of blood-brain barrier induced by repeated administration of endothelin-1 in dogs and rats. Pharmacol. Toxicol. 92 (2003), 21–26.
142. Naus, C.C., Bechberger, J.F., Zhang, Y., Venance, L., Yamasaki, H., Juneja, S.C., Kidder, G.M., Giaume, C., Altered gap junctional communication, intercellular signaling, and growth in cultured astrocytes deficient in connexin43. J. Neurosci. Res. 49 (1997), 528–540.
143. Nelson, J., Bagnato, A., Battistini, B., Nisen, P., The endothelin axis: emerging role in cancer. Nat. Rev. Cancer 3 (2003), 110–116.
144. Neuschmelting, V., Marbacher, S., Fathi, A.R., Jakob, S.M., Fandino, J., Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associated with cerebral vasospasm after subarachnoid haemorrhage in rabbits. Acta Neurochir. (Wien) 151 (2009), 795–801 discussion 801–792.
145. Nie, X.J., Hoog, A., Jiang, M.H., Ma, K.C., Olsson, Y., Zhang, W.W., Endothelin-like immunoreactivity is expressed in reactive astrocytes in cases of cerebral infarcts and lacunes. Eur. J. Neurol. 1 (1994), 135–140.
146. Ohta, H., Nishikawa, H., Kimura, H., Anayama, H., Miyamoto, M., Chronic cerebral hypoperfusion by permanent internal carotid ligation produces learning impairment without brain damage in rats. Neuroscience 79 (1997), 1039–1050.
147. Opgenorth, T.J., Wessale, J.L., Dixon, D.B., Adler, A.L., Calzadilla, S.V., Padley, R.J., Wu-Wong, J.R., Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level. J. Cardiovasc. Pharmacol. 36 (2000), S292–296.
148. Ostrow, L.W., Suchyna, T.M., Sachs, F., Stretch induced endothelin-1 secretion by adult rat astrocytes involves calcium influx via stretch-activated ion channels (SACs). Biochem. Biophys. Res. Commun. 410 (2011), 81–86.
149. Ouardouz, M., Coderre, E., Basak, A., Chen, A., Zamponi, G.W., Hameed, S., Rehak, R., Yin, X., Trapp, B.D., Stys, P.K., Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann. Neurol. 65 (2009), 151–159.
150. Ouardouz, M., Coderre, E., Zamponi, G.W., Hameed, S., Yin, X., Trapp, B.D., Stys, P.K., Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann. Neurol. 65 (2009), 160–166.
151. Pagotto, U., Arzberger, T., Hopfner, U., Weindl, A., Stalla, G.K., Cellular localization of endothelin receptor mRNAs (ETA and ETB) in brain tumors and normal human brain. J. Cardiovasc. Pharmacol. 26:Suppl. 3 (1995), S104–S106.
152. Palmer, J., Love, S., Endothelin receptor antagonists: potential in Alzheimer's disease. Pharmacol. Res. 63 (2011), 525–531.
153. Palmer, J.C., Baig, S., Kehoe, P.G., Love, S., Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta. Am. J. Pathol. 175 (2009), 262–270.
154. Palmer, J.C., Barker, R., Kehoe, P.G., Love, S., Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-beta. J. Alzheimers Dis. 29 (2012), 853–861.
155. Palmer, J.C., Tayler, H.M., Love, S., Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's disease. J. Alzheimers Dis. 36 (2013), 577–587.
156. Paolillo, M., Barbieri, A., Zanassi, P., Schinelli, S., Expression of endothelins and their receptors in glioblastoma cell lines. J. Neurooncol. 79 (2006), 1–7.
157. Paolillo, M., Russo, M.A., Curti, D., Lanni, C., Schinelli, S., Endothelin B receptor antagonists block proliferation and induce apoptosis in glioma cells. Pharmacol. Res. 61 (2010), 306–315.
158. Pappas, B.A., de la Torre, J.C., Davidson, C.M., Keyes, M.T., Fortin, T., Chronic reduction of cerebral blood flow in the adult rat: late-emerging CA1 cell loss and memory dysfunction. Brain Res. 708 (1996), 50–58.
159. Pekny, M., Pekna, M., Messing, A., Steinhauser, C., Lee, J.M., Parpura, V., Hol, E.M., Sofroniew, M.V., Verkhratsky, A., Astrocytes: a central element in neurological diseases. Acta Neuropathol. 131 (2016), 323–345.
160. Peters, C.M., Rogers, S.D., Pomonis, J.D., Egnaczyk, G.F., Keyser, C.P., Schmidt, J.A., Ghilardi, J.R., Maggio, J.E., Mantyh, P.W., Endothelin receptor expression in the normal and injured spinal cord: potential involvement in injury-induced ischemia and gliosis. Exp. Neurol. 180 (2003), 1–13.
161. Petrov, T., Amelioration of hypoperfusion after traumatic brain injury by in vivo endothelin-1 knockout. Can. J. Physiol. Pharmacol. 87 (2009), 379–386.
162. Pluta, R.M., Boock, R.J., Afshar, J.K., Clouse, K., Bacic, M., Ehrenreich, H., Oldfield, E.H., Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J. Neurosurg. 87 (1997), 287–293.
163. Ranno, E., D'Antoni, S., Spatuzza, M., Berretta, A., Laureanti, F., Bonaccorso, C.M., Pellitteri, R., Longone, P., Spalloni, A., Iyer, A.M., Aronica, E., Catania, M.V., Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death. Neurobiol. Dis. 65 (2014), 160–171.
164. Rogers, S.D., Peters, C.M., Pomonis, J.D., Hagiwara, H., Ghilardi, J.R., Mantyh, P.W., Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS. Glia 41 (2003), 180–190.
165. Rolinski, B., Heigermoser, A., Lederer, E., Bogner, J.R., Loch, O., Goebel, F.D., Endothelin-1 is elevated in the cerebrospinal fluid of HIV-infected patients with encephalopathy. Infection 27 (1999), 244–247.
166. Roman, G., Erkinjuntti, T., Wallin, A., Pantoni, L., Chui, H., Subcortical ischemic vascular dementia. Lancet Neurol. 1 (2002), 426–436.
167. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P., Deng, H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993), 59–62.
168. Rozyczka, J., Figiel, M., Engele, J., Chronic endothelin exposure inhibits connexin43 expression in cultured cortical astroglia. J. Neurosci. Res. 79 (2005), 303–309.
169. Rubin, S.A., Levin, E.R., Clinical review 53: the endocrinology of vasoactive peptides: synthesis to function. J. Clin. Endocrinol. Metab. 78 (1994), 6–10.
170. Sanchez-Alvarez, R., Tabernero, A., Medina, J.M., Endothelin-1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: relationship with gap junctional communication. J. Neurochem. 89 (2004), 703–714.
171. Sanchez-Gomez, M.V., Matute, C., Activation of AMPA and kainate glutamate receptors impairs the viability of oligodendrocytes in vitro. Int. J. Dev. Biol., 1996, 187S–188S.
172. Sapira, V., Cojocaru, I.M., Lilios, G., Grigorian, M., Cojocaru, M., Study of endothelin-1 in acute ischemic stroke. Rom. J. Intern. Med. 48 (2010), 329–332.
173. Sharp, F.R., Bernaudin, M., HIF1 and oxygen sensing in the brain. Nat. Rev. Neurosci. 5 (2004), 437–448.
174. Shen, C., Yang, L., Yuan, X., Endothelin B receptor expression in human astrocytoma: association with clinicopathological variables and survival outcomes. Int. J. Neurosci. 121 (2011), 626–631.
175. Shibaguchi, H., Himeno, A., Shigematsu, K., Kataoka, Y., Niwa, M., Transient hypoxia/hypoglycemia upregulates endothelin B receptors in cultured rat astrocytes. Glia 31 (2000), 91–94.
176. Shin, T., Kang, B., Tanuma, N., Matsumoto, Y., Wie, M., Ahn, M., Kang, J., Intrathecal administration of endothelin-1 receptor antagonist ameliorates autoimmune encephalomyelitis in Lewis rats. Neuroreport 12 (2001), 1465–1468.
177. Sibson, N.R., Blamire, A.M., Perry, V.H., Gauldie, J., Styles, P., Anthony, D.C., TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway. Brain 125 (2002), 2446–2459.
178. Siren, A.L., Knerlich, F., Schilling, L., Kamrowski-Kruck, H., Hahn, A., Ehrenreich, H., Differential glial and vascular expression of endothelins and their receptors in rat brain after neurotrauma. Neurochem. Res. 25 (2000), 957–969.
179. Sluck, J.M., Lin, R.C., Katolik, L.I., Jeng, A.Y., Lehmann, J.C., Endothelin converting enzyme-1-, endothelin-1-, and endothelin-3-like immunoreactivity in the rat brain. Neuroscience 91 (1999), 1483–1497.
180. Sone, M., Takahashi, K., Totsune, K., Murakami, O., Arihara, Z., Satoh, F., Mouri, T., Shibahara, S., Expression of endothelin-1 and endothelin receptors in cultured human glioblastoma cells. J. Cardiovasc. Pharmacol. 36 (2000), S390–392.
181. Speciale, L., Sarasella, M., Ruzzante, S., Caputo, D., Mancuso, R., Calvo, M.G., Guerini, F.R., Ferrante, P., Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis. J. Neurovirol. 6:Suppl. 2 (2000), S62–S66.
182. Stiles, J.D., Ostrow, P.T., Balos, L.L., Greenberg, S.J., Plunkett, R., Grand, W., Heffner, R.R. Jr., Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas. J. Neuropathol. Exp. Neurol. 56 (1997), 435–439.
183. Stokely, M.E., Yorio, T., King, M.A., Endothelin-1 modulates anterograde fast axonal transport in the central nervous system. J. Neurosci. Res. 79 (2005), 598–607.
184. Tabernero, A., Giaume, C., Medina, J.M., Endothelin-1 regulates glucose utilization in cultured astrocytes by controlling intercellular communication through gap junctions. Glia 16 (1996), 187–195.
185. Tabernero, A., Sanchez-Alvarez, R., Medina, J.M., Increased levels of cyclins D1 and D3 after inhibition of gap junctional communication in astrocytes. J. Neurochem. 96 (2006), 973–982.
186. Tatlisumak, T., Carano, R.A., Takano, K., Opgenorth, T.J., Sotak, C.H., Fisher, M., A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study. Stroke 29 (1998), 850–857 discussion 857–858.
187. Teixeira, A., Chaverot, N., Strosberg, A.D., Cazaubon, S., Differential regulation of cyclin D1 and D3 expression in the control of astrocyte proliferation induced by endothelin-1. J. Neurochem. 74 (2000), 1034–1040.
188. Thomas, T., Miners, S., Love, S., Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia. Brain 138 (2015), 1059–1069.
189. Tomimoto, H., Ihara, M., Wakita, H., Ohtani, R., Lin, J.X., Akiguchi, I., Kinoshita, M., Shibasaki, H., Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol. 106 (2003), 527–534.
190. Tsang, M.C., Lo, A.C., Cheung, P.T., Chung, S.S., Chung, S.K., Perinatal hypoxia-/ischemia-induced endothelin-1 mRNA in astrocyte-like and endothelial cells. Neuroreport 12 (2001), 2265–2270.
191. Tuschick, S., Kirischuk, S., Kirchhoff, F., Liefeldt, L., Paul, M., Verkhratsky, A., Kettenmann, H., Bergmann glial cells in situ express endothelinB receptors linked to cytoplasmic calcium signals. Cell Calcium 21 (1997), 409–419.
192. Uhl, E., Beck, J., Stummer, W., Lehmberg, J., Baethmann, A., Leukocyte-endothelium interactions in pial venules during the early and late reperfusion period after global cerebral ischemia in gerbils. J. Cereb. Blood Flow Metab. 20 (2000), 979–987.
193. Walter, L., Stella, N., Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes. Glia 44 (2003), 85–90.
194. Walter, L., Franklin, A., Witting, A., Moller, T., Stella, N., Astrocytes in culture produce anandamide and other acylethanolamides. J. Biol. Chem. 277 (2002), 20869–20876.
195. Wang, Y., Qin, Z.H., Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15 (2010), 1382–1402.
196. Wang, X., Li, Y.M., Li, W.Q., Huang, C.G., Lu, Y.C., Hou, L.J., Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials. PLoS One, 7, 2012, e47778.
197. Webster Crowley, R., Medel, R., Kassell, N.F., Dumont, A.S., New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage. Drug Discov. Today 13 (2008), 254–260.
198. Wosik, K., Antel, J., Kuhlmann, T., Bruck, W., Massie, B., Nalbantoglu, J., Oligodendrocyte injury in multiple sclerosis: a role for p53. J. Neurochem. 85 (2003), 635–644.
199. Xu, J.Y., Chen, C., Endocannabinoids in synaptic plasticity and neuroprotection. Neuroscientist 21 (2015), 152–168.
200. Yamashita, K., Discher, D.J., Hu, J., Bishopric, N.H., Webster, K.A., Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J. Biol. Chem. 276 (2001), 12645–12653.
201. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., Masaki, T., A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988), 411–415.
202. Yeung, P.K., Lo, A.C., Leung, J.W., Chung, S.S., Chung, S.K., Targeted overexpression of endothelin-1 in astrocytes leads to more severe cytotoxic brain edema and higher mortality. J. Cereb. Blood Flow Metab. 29 (2009), 1891–1902.
203. Yin, X., Liu, C., Gui, L., Zhao, L., Zhang, J., Wei, L., Xie, B., Zhou, D., Li, C., Wang, J., Comparison of medial temporal measures between Binswanger's disease and Alzheimer's disease. PLoS One, 9, 2014, e86423.
204. Zhang, W.W., Badonic, T., Hoog, A., Jiang, M.H., Ma, K.C., Nie, J.X., Olsson, Y., Sourander, P., Structural and vasoactive factors influencing intracerebral arterioles in cases of vascular dementia and other cerebrovascular disease: a review. Immunohistochemical studies on expression of collagens, basal lamina components and endothelin-1. Dementia 5 (1994), 153–162.
205. Zhang, W.W., Badonic, T., Hoog, A., Jiang, M.H., Ma, K.C., Nie, X.J., Olsson, Y., Astrocytes in Alzheimer's disease express immunoreactivity to the vaso-constrictor endothelin-1. J. Neurol. Sci. 122 (1994), 90–96.